AT&T has landed at top spot on CR Magazine's 14th annual 100 Best Corporate Citizens List, beating out other top Russell 1000 large-capitalization companies on merits including human rights and corporate governance.

Rounding out the top 10 on the new list: Mattel, Bristol-Myers Squibb, Eaton Corp, Intel, Gap, Hasbro, Merck & Co., Campbell Soup Co. and Coca-Cola. 

The ranking crunches 298 data points of disclosure and performance measures across seven categories: environment, climate change, employee relations, human rights, governance, finance and philanthropy. 

Notably, 26 companies on the 2013 list were not on the 2012 list, while 11 companies have appeared on the list every year since 2007. For those that were bestowed the honor, many were quick to highlight the significance of employee participation to the success of the company's initiatives.Continue reading...

Arthur Frommer buys back travel book brand from Google, which acquired it with big plans last August.

Facebook readies for rumored phone event today.

Apple's futuristic campus project runs late and $2 billion overbudget.

BlackBerry turns mobile website into "test drive" of new Z10 phone, kills off BBM music service.

CVS and Rite-Aid target allergy season.

ConAgra boosts ad spending as commodity costs drop.

Detroit Electric launches Tesla rival.Continue reading...

Boeing's troubled 787 Dreamliner grounded in Japan.

JPMorgan cuts Jamie Dimon's pay, tops estimates with profit.

Dell falls from PC king to buyout fodder.

Apollo Group to offer course on innovation.

Audi bows out of sponsoring inaugural this time around.

Boeing sees Dreamliner make another emergency landing, in Japan.

Bristol-Myers Squibb plans to discuss settling Hepatitis C claims.Continue reading...

Apple and Samsung wait for jury to plow through complex case as Apple tries to thwart efforts by Google and its Motorola Mobility to ban iPhone and iPad imports into U.S.

Lance Armstrong says he'll stop fighting U.S. doping authority, faces loss of Tour de France titles.

Best Buy carries out drama with founder over control of company.

Boeing strains to make Dreamliner program profitable.

Bristol-Myers Squibb drops Hepatitis C drug after patient death.

Chrysler mulls boosting Ram truck production to meet rising demand.

Cox Communications debuts multi-platform football-based campaign.

Current TV to turn over half the screen to Twitter during convention coverage.

Daimler mulls building compact Mercedes cars with Renault-Nissan, report says. Continue reading...

Apple pays $60M to end iPad trademark dispute in China, looks to secure ipad3.com domain.

Barclays scandal forces out chairman, saying "the buck stops with me."

Bristol-Myers agrees to buy Amylin Pharmaceuticals for $5B in cash, expands diabetes alliance.

Rupert Murdoch will rebrand the Wall Street Journal as WSJ as part of News Corp. split.

AMC parent ends AT&T U-verse TV dispute with long-term agreement, as Dish feud continues.

Applebee's rolls out fresh menu, look and campaign.Continue reading...

Dish Network runs into resistance for placing its ad about its ad-skipping DVR.

Pinterest valued at $1.5 billion.

Unilever tests interactive TV concept with NBCU.

Angry Birds footwear? Check.

Apple awarded U.S. patent for soft keyboard as Retina Display patent application for OSX revealed.

Boyd Gaming to buy Peninsula Gaming.

Bristol-Myers Squibb set to lose patent protection for Plavix.

Buca di Beppo has aggressive growth in sight, new CEO says.

CNN hits 15-year low with prime-time ratings.

Comcast's NBC Sports Network will break cable record for Olympics coverage.

Facebook confronts skepticism about its advertising in wake of GM pullout.Continue reading...

Amazon plans to republish James Bond novel series.

Apple and Samsung are ordered into a patent-settlement conference, while Apple pressures Beijing with iPad snub.

Eatzi's expands into new locations.

Berkshire Hathaway will remain firmly under Warren Buffett's control as he undergoes prostate-cancer treatment.

Best Buy sees CEO search influenced by founder.

Bristol-Myers Squibb tops Corporate Responsibility Magazine's Best Corporate Citizens 2012 ranking.

Chevrolet touts Volt with Klout.

Citicorp sees executive pay plan ovewhelmingly rejected by shareholders.Continue reading...

Merck & Co.’s HIV-fighting drug Isentress has been on the market for adults since October of 2007. Now the FDA is letting Merck market the product to children and teens, the Wall Street Journal reports.

Isentress is what’s known as an “HIV integrase inhibitors,” that “work(s) by interfering with the virus's ability to replicate itself,” the Journal notes. 

U.S. clinical trials were done with the drug on 96 children and teens between the ages of 2 and 18 years old with HIV. It “found that 53% of these patients had an undetectable amount of HIV in their blood after 24 weeks of treatment with the drug,” WSJ adds.

Merck also is joining five other drug manufacturers to provide discounts on HIV drugs to state drug-assistance programs, according to FiercePharma.com. Starting this week, Merck is discounting Isentress through 2013 to help out the National Alliance of State and Territorial AIDS Directors.

"With the economy the way it is, there are many more people without jobs and many more people who are qualifying for the programs," said Murray Penner, the organization's deputy executive director. "The need has ballooned."

Johnson & Johnson, Bristol-Myers Squibb, Gilead Sciences, Boehringer Ingelheim and the Pfizer/GlaxoSmithKline joint venture ViiV Healthcare have all also discounted drugs for the state programs.